エル・ティー・エスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/25 | 2,764 | 2,850 | 2,738 | 2,814 | +55 | +2% | 26,400 |
2023/01/24 | 2,779 | 2,809 | 2,759 | 2,759 | -22 | -0.8% | 15,300 |
2023/01/23 | 2,850 | 2,855 | 2,730 | 2,781 | -64 | -2.2% | 38,400 |
2023/01/20 | 2,714 | 2,880 | 2,714 | 2,845 | +146 | +5.4% | 44,400 |
2023/01/19 | 2,662 | 2,727 | 2,661 | 2,699 | -1 | ±0% | 16,700 |
2023/01/18 | 2,770 | 2,776 | 2,675 | 2,700 | -70 | -2.5% | 40,000 |
2023/01/17 | 2,729 | 2,798 | 2,725 | 2,770 | +22 | +0.8% | 19,600 |
2023/01/16 | 2,687 | 2,817 | 2,687 | 2,748 | +55 | +2% | 16,200 |
2023/01/13 | 2,697 | 2,728 | 2,674 | 2,693 | -2 | -0.1% | 7,800 |
2023/01/12 | 2,748 | 2,748 | 2,674 | 2,695 | -55 | -2% | 11,100 |
2023/01/11 | 2,735 | 2,797 | 2,735 | 2,750 | +15 | +0.5% | 13,500 |
2023/01/10 | 2,701 | 2,800 | 2,701 | 2,735 | +56 | +2.1% | 12,200 |
2023/01/06 | 2,656 | 2,763 | 2,655 | 2,679 | -12 | -0.4% | 14,800 |
2023/01/05 | 2,752 | 2,759 | 2,663 | 2,691 | -56 | -2% | 24,200 |
2023/01/04 | 2,839 | 2,839 | 2,739 | 2,747 | -77 | -2.7% | 11,700 |
2022/12/30 | 2,842 | 2,905 | 2,824 | 2,824 | -18 | -0.6% | 12,600 |
2022/12/29 | 2,790 | 2,879 | 2,783 | 2,842 | +23 | +0.8% | 13,600 |
2022/12/28 | 2,833 | 2,851 | 2,767 | 2,819 | -35 | -1.2% | 13,200 |
2022/12/27 | 2,858 | 2,900 | 2,821 | 2,854 | +4 | +0.1% | 21,000 |
2022/12/26 | 2,728 | 2,879 | 2,728 | 2,850 | +129 | +4.7% | 36,000 |
2022/12/23 | 2,786 | 2,811 | 2,721 | 2,721 | -79 | -2.8% | 16,800 |
2022/12/22 | 2,946 | 2,946 | 2,792 | 2,800 | -104 | -3.6% | 23,600 |
2022/12/21 | 2,883 | 2,975 | 2,847 | 2,904 | +21 | +0.7% | 13,400 |
2022/12/20 | 3,020 | 3,050 | 2,825 | 2,883 | -127 | -4.2% | 48,500 |
2022/12/19 | 3,010 | 3,115 | 3,010 | 3,010 | -35 | -1.1% | 20,400 |
2022/12/16 | 3,005 | 3,155 | 3,005 | 3,045 | -30 | -1% | 28,600 |
2022/12/15 | 3,065 | 3,115 | 2,990 | 3,075 | -25 | -0.8% | 40,700 |
2022/12/14 | 3,175 | 3,175 | 3,070 | 3,100 | -75 | -2.4% | 23,700 |
2022/12/13 | 3,190 | 3,195 | 3,100 | 3,175 | +20 | +0.6% | 41,400 |
2022/12/12 | 3,190 | 3,280 | 3,145 | 3,155 | -35 | -1.1% | 25,200 |
2022/12/09 | 3,365 | 3,365 | 3,150 | 3,190 | -225 | -6.6% | 88,200 |
2022/12/08 | 3,615 | 3,645 | 3,380 | 3,415 | -305 | -8.2% | 50,300 |
2022/12/07 | 3,745 | 3,750 | 3,630 | 3,720 | -50 | -1.3% | 18,900 |
2022/12/06 | 3,860 | 3,860 | 3,695 | 3,770 | -70 | -1.8% | 28,000 |
2022/12/05 | 3,705 | 3,875 | 3,685 | 3,840 | +70 | +1.9% | 37,500 |
2022/12/02 | 3,530 | 3,770 | 3,475 | 3,770 | +210 | +5.9% | 49,700 |
2022/12/01 | 3,520 | 3,565 | 3,420 | 3,560 | +65 | +1.9% | 16,800 |
2022/11/30 | 3,550 | 3,550 | 3,495 | 3,495 | -65 | -1.8% | 6,200 |
2022/11/29 | 3,480 | 3,570 | 3,420 | 3,560 | +35 | +1% | 13,300 |
2022/11/28 | 3,535 | 3,580 | 3,495 | 3,525 | -10 | -0.3% | 15,500 |
2022/11/25 | 3,350 | 3,535 | 3,325 | 3,535 | +195 | +5.8% | 20,500 |
2022/11/24 | 3,385 | 3,495 | 3,340 | 3,340 | -15 | -0.4% | 31,800 |
2022/11/22 | 3,145 | 3,355 | 3,145 | 3,355 | +230 | +7.4% | 35,800 |
2022/11/21 | 2,998 | 3,240 | 2,998 | 3,125 | +149 | +5% | 49,900 |
2022/11/18 | 2,997 | 3,020 | 2,970 | 2,976 | -5 | -0.2% | 8,000 |
2022/11/17 | 2,968 | 3,040 | 2,965 | 2,981 | -13 | -0.4% | 15,300 |
2022/11/16 | 2,894 | 2,994 | 2,894 | 2,994 | +83 | +2.9% | 13,800 |
2022/11/15 | 3,000 | 3,050 | 2,900 | 2,911 | -154 | -5% | 28,300 |
2022/11/14 | 2,851 | 3,135 | 2,851 | 3,065 | +35 | +1.2% | 38,900 |
2022/11/11 | 3,025 | 3,035 | 2,990 | 3,030 | +48 | +1.6% | 14,500 |
451~
500
件表示中 / 1694件
類似銘柄と比較する
現在ご覧いただいている「LTS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
LTS | 230,600円 | +34.8% | +52.7% | 1.30% | 10.71倍 | 2.74倍 |
|
ビジネスプロセス可視化・改善・実行支援など展開、ITビジネスマッチング「アサインナビ」も |
メドピア | 49,100円 | -17.1% | -35.1% | 0.92% | 21.33倍 | 1.13倍 |
|
医師向け情報サイト運営、製薬会社の広告料が収益源。法人向け医療相談や特定保健指導も展開 |
FCE | 97,200円 | +14.9% | +29.6% | 1.44% | 16.86倍 | 3.15倍 |
|
業務改善用RPAソフトでDX支援。クラウドサービスでeラーニング展開。配当性向25%目安 |
MDNT | 4,000円 | +21.1% | - | 0.00% | - | 2.04倍 |
|
東大医科研発。がん免疫細胞療法の細胞加工が核。医薬品開発、医薬品受託製造(CDMO)も |
ZETA | 40,900円 | -54.0% | - | 1.71% | 282.07倍 | 7.62倍 |
|
ZETAを子会社化しビッグデータ活用の推奨商品表示(CX改善)が柱に。ネット広告は撤退 |
市場注目の銘柄
チャート関連のコラム